https://www.gov.uk
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion purchase by
Stryker and Wright both manufacture a range of orthopaedic products for patients requiring assistance with their feet, ankles and hands. The total ankle replacement prosthetics produced by Stryker and Wright are predominantly used in elderly orthopaedic patients suffering from arthritis.
Following its initial Phase 1 investigation, the CMA found that the proposed merger would result in the merged entity having a share of over 90% in the total ankle replacement prostheses market in the
The CMA is concerned that this merger and the resulting reduction in competition could lead to worse outcomes for hospitals and patients. The companies are the two major producers of vital medical products for vulnerable people suffering from serious degenerative conditions such as arthritis.
Healthy competition in the medical technology market is central to continued innovation and improvements in patient treatments.
Stryker and Wright now have until
For more information, visit the Stryker/
For media enquiries, contact the CMA press office on 020 3738 6460 or press@cma.gov.uk.
.
(C) 2020 M2 COMMUNICATIONS, source